Review




Structured Review

Jackson Laboratory b6 x dba2 f1 mice
B6 X Dba2 F1 Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dba2/dba+2+mice/pm38810258-23-3-21
Average 90 stars, based on 1 article reviews
b6 x dba2 f1 mice - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

Injection:

Article Title: In Silico Structural Prediction for the Generation of Novel Performant Midi-Dystrophins Based on Intein-Mediated Dual AAV Approach.
Article Snippet: DBA2 (B6;129S4-DBA2tm1Cpr/J, strain #000671) and DBA2-mdx (D2.B10-Dmdmdx/J) mice were supplied by the Jackson Laboratory.

Article Title: Suppression of NRF2-dependent cancer growth by a covalent allosteric molecular glue
Article Snippet: 2X10 5 KLN-205 cells per mouse were subcutaneously implanted in DBA/2 mice (Jackson Laboratory).

Article Title: Suppression of NRF2-dependent cancer growth by a covalent allosteric molecular glue
Article Snippet: KLN-205 cells were harvested in exponential growth phase and suspended in 100 uL PBS to deliver 0.5×10 6 cells via a tail vein injection in DBA/2 mice (Jackson Laboratory).

Article Title: Enhanced Synaptic Inhibition in the Dorsolateral Geniculate Nucleus in a Mouse Model of Glaucoma
Article Snippet: For this study, we used male and female DBA/2J (D2; Jackson Laboratory 000671; RRID, IMSR_JAX:000671; ) and DBA/2J gpnmb+ (D2-control; Jackson Laboratory 007048; RRID, IMSR_JAX:007048; ) mice, aged 10–14 months.

Article Title: Multi-COBRA hemagglutinin formulated with cGAMP microparticles elicits protective immune responses against influenza viruses.
Article Snippet: In humans, seasonal influenza viruses cause epidemics.. Avian influenza viruses are of particular concern because they can infect multiple species and lead to unpredictable and severe disease.. Therefore, there is an urgent need for a univer sal influenza vaccine that provides protection against all influenza strains.

Article Title: Butyrophilin 2A2 promotes T cell immunoregulation by enhancing CD45 phosphatase activity within the immune synapse
Article Snippet: DBA/2 and CBA/J mice were purchased from Jackson Laboratory.

Article Title: Stenotrophomonas maltophilia provokes NEU1-mediated release of a flagellin-binding decoy receptor that protects against lethal infection
Article Snippet: Equal numbers of male and female adult DBA/2 mice (18–20 g, 20–22 weeks) (The Jackson Laboratory, Bar Harbor, ME) were randomly assigned to the experimental groups and administered i.n. with 1.0 × 10 8 CFU/mouse of the flagellin-expressing WT Sm strain, the flagellin-null Sm strain, or PBS control.

Article Title: AMPK drives both glycolytic and oxidative metabolism in murine and human T cells during graft-versus-host disease.
Article Snippet: C57BL/6 (B6, H2b), B6 x DBA2 F1 (B6D2F1), CD45.1 (B6.SJLPtprcaPepcb/BoyJ), CD4cre (B6.Cg-Tg(Cd4-cre)1Cwi/BfluJ), NSG (NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ), and Thy1.1 (B6.PL-Thy1a/CyJ) mice were purchased from Jackson Laboratories.



Similar Products

86
Charles River Laboratories old dba2
Old Dba2, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dba2/balb+c+mice/us12497443-245-7-9
Average 86 stars, based on 1 article reviews
old dba2 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Charles River Laboratories dba2
Combined therapy: Gene transfer efficiency (A) Schematic representation of the in vivo protocol. Two-month-old D2.Mdx mice were injected or not with two consecutive doses (1 × 10 6 ) of control T cells or of FAP-CAR-T cells, and after 2 weeks of treatment the mice were injected with a single intravenous dose (5 × 10 12 VG/kg) of rAAV9-microdystrophin (μDystrophin or μDys). Tissues were collected 6 weeks after the AAV injection, 4 animals were included per group and statistical analyses used one-way ANOVA tests with p values indicated above the compared conditions. (B) Quantification of VGCN with ddPCR in TA, EDL, and DIA in <t>DBA2-MDX</t> mice. (C) Gene expression analysis of microdystrophin in TA, EDL, and DIA of DBA2-MDX mice. Results are shown as a histogram of relative abundance of gene expression over P0 normalizer gene. (D) Quantification of microdystrophin expression after capillary western blot with DYS-B antibody in TA, EDL, and DIA at 6 weeks post-injection in mice. Values are represented as normalized area under the curve (AUC). (E) Capillary western blot of protein lysates of TA at 6 weeks post-injection in mice. Microdystrophin are visible around 139 kDa. (F) Representative microdystrophin IHF pictures of the TA, EDL, and DIA at 6 weeks post-injection in mice. Images include a scale bar. (G) Quantification of dystrophin positive myofibers in TA, EDL, and DIA at 6 weeks post-injection in D2.mdx mice. The percentage of dystrophin+ fibers is represented of number of dystrophin positive fibers over fibers positive for laminin.
Dba2, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dba2/balb+c+mice/pmc12396263-202-1-14
Average 86 stars, based on 1 article reviews
dba2 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
HFK Bioscience dba2/j (d2) male mice
Combined therapy: Gene transfer efficiency (A) Schematic representation of the in vivo protocol. Two-month-old D2.Mdx mice were injected or not with two consecutive doses (1 × 10 6 ) of control T cells or of FAP-CAR-T cells, and after 2 weeks of treatment the mice were injected with a single intravenous dose (5 × 10 12 VG/kg) of rAAV9-microdystrophin (μDystrophin or μDys). Tissues were collected 6 weeks after the AAV injection, 4 animals were included per group and statistical analyses used one-way ANOVA tests with p values indicated above the compared conditions. (B) Quantification of VGCN with ddPCR in TA, EDL, and DIA in <t>DBA2-MDX</t> mice. (C) Gene expression analysis of microdystrophin in TA, EDL, and DIA of DBA2-MDX mice. Results are shown as a histogram of relative abundance of gene expression over P0 normalizer gene. (D) Quantification of microdystrophin expression after capillary western blot with DYS-B antibody in TA, EDL, and DIA at 6 weeks post-injection in mice. Values are represented as normalized area under the curve (AUC). (E) Capillary western blot of protein lysates of TA at 6 weeks post-injection in mice. Microdystrophin are visible around 139 kDa. (F) Representative microdystrophin IHF pictures of the TA, EDL, and DIA at 6 weeks post-injection in mice. Images include a scale bar. (G) Quantification of dystrophin positive myofibers in TA, EDL, and DIA at 6 weeks post-injection in D2.mdx mice. The percentage of dystrophin+ fibers is represented of number of dystrophin positive fibers over fibers positive for laminin.
Dba2/J (D2) Male Mice, supplied by HFK Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dba2/dba+1+mice/pmc11862900-36-0-8
Average 90 stars, based on 1 article reviews
dba2/j (d2) male mice - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Jackson Laboratory dba2/j mice
Combined therapy: Gene transfer efficiency (A) Schematic representation of the in vivo protocol. Two-month-old D2.Mdx mice were injected or not with two consecutive doses (1 × 10 6 ) of control T cells or of FAP-CAR-T cells, and after 2 weeks of treatment the mice were injected with a single intravenous dose (5 × 10 12 VG/kg) of rAAV9-microdystrophin (μDystrophin or μDys). Tissues were collected 6 weeks after the AAV injection, 4 animals were included per group and statistical analyses used one-way ANOVA tests with p values indicated above the compared conditions. (B) Quantification of VGCN with ddPCR in TA, EDL, and DIA in <t>DBA2-MDX</t> mice. (C) Gene expression analysis of microdystrophin in TA, EDL, and DIA of DBA2-MDX mice. Results are shown as a histogram of relative abundance of gene expression over P0 normalizer gene. (D) Quantification of microdystrophin expression after capillary western blot with DYS-B antibody in TA, EDL, and DIA at 6 weeks post-injection in mice. Values are represented as normalized area under the curve (AUC). (E) Capillary western blot of protein lysates of TA at 6 weeks post-injection in mice. Microdystrophin are visible around 139 kDa. (F) Representative microdystrophin IHF pictures of the TA, EDL, and DIA at 6 weeks post-injection in mice. Images include a scale bar. (G) Quantification of dystrophin positive myofibers in TA, EDL, and DIA at 6 weeks post-injection in D2.mdx mice. The percentage of dystrophin+ fibers is represented of number of dystrophin positive fibers over fibers positive for laminin.
Dba2/J Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dba2/c57bl+6j+mice/pm39587144-252-1-10
Average 90 stars, based on 1 article reviews
dba2/j mice - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
Jackson Laboratory mouse strain dba2 j
Combined therapy: Gene transfer efficiency (A) Schematic representation of the in vivo protocol. Two-month-old D2.Mdx mice were injected or not with two consecutive doses (1 × 10 6 ) of control T cells or of FAP-CAR-T cells, and after 2 weeks of treatment the mice were injected with a single intravenous dose (5 × 10 12 VG/kg) of rAAV9-microdystrophin (μDystrophin or μDys). Tissues were collected 6 weeks after the AAV injection, 4 animals were included per group and statistical analyses used one-way ANOVA tests with p values indicated above the compared conditions. (B) Quantification of VGCN with ddPCR in TA, EDL, and DIA in <t>DBA2-MDX</t> mice. (C) Gene expression analysis of microdystrophin in TA, EDL, and DIA of DBA2-MDX mice. Results are shown as a histogram of relative abundance of gene expression over P0 normalizer gene. (D) Quantification of microdystrophin expression after capillary western blot with DYS-B antibody in TA, EDL, and DIA at 6 weeks post-injection in mice. Values are represented as normalized area under the curve (AUC). (E) Capillary western blot of protein lysates of TA at 6 weeks post-injection in mice. Microdystrophin are visible around 139 kDa. (F) Representative microdystrophin IHF pictures of the TA, EDL, and DIA at 6 weeks post-injection in mice. Images include a scale bar. (G) Quantification of dystrophin positive myofibers in TA, EDL, and DIA at 6 weeks post-injection in D2.mdx mice. The percentage of dystrophin+ fibers is represented of number of dystrophin positive fibers over fibers positive for laminin.
Mouse Strain Dba2 J, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dba2/dba2+j+mouse+strain/pmc10655617-794-0-5
Average 86 stars, based on 1 article reviews
mouse strain dba2 j - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Jackson Laboratory dba2
Figure 4. Efficacy of reconstitution of midi-dystrophins in <t>Dba2-mdx</t> mouse model. (A) Schematic representation of the in vivo protocol. One month old Dba2/mdx mice were injected with midi-Dys 1, midi-Dys 2, and midi-Dys 3 at a dose of 2.0 × 1013 vg/kg each vector (total dose 4.0 × 1013 vg/kg).
Dba2, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dba2/2+dba/pm39408775-325-0-11
Average 86 stars, based on 1 article reviews
dba2 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Jackson Laboratory dba2-mdx (d2.b10-dmdmdx/j) mice
Figure 4. Efficacy of reconstitution of midi-dystrophins in <t>Dba2-mdx</t> mouse model. (A) Schematic representation of the in vivo protocol. One month old Dba2/mdx mice were injected with midi-Dys 1, midi-Dys 2, and midi-Dys 3 at a dose of 2.0 × 1013 vg/kg each vector (total dose 4.0 × 1013 vg/kg).
Dba2 Mdx (D2.B10 Dmdmdx/J) Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dba2/dba+2+mice/pm39408775-325-5-12
Average 90 stars, based on 1 article reviews
dba2-mdx (d2.b10-dmdmdx/j) mice - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
Jackson Laboratory dba2 mdx d2 b10 dmdmdx j mice
Figure 4. Efficacy of reconstitution of midi-dystrophins in <t>Dba2-mdx</t> mouse model. (A) Schematic representation of the in vivo protocol. One month old Dba2/mdx mice were injected with midi-Dys 1, midi-Dys 2, and midi-Dys 3 at a dose of 2.0 × 1013 vg/kg each vector (total dose 4.0 × 1013 vg/kg).
Dba2 Mdx D2 B10 Dmdmdx J Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dba2/mdx+mice/pm39408775-325-5-11
Average 86 stars, based on 1 article reviews
dba2 mdx d2 b10 dmdmdx j mice - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Jackson Laboratory b6 x dba2 f1 mice
Figure 4. Efficacy of reconstitution of midi-dystrophins in <t>Dba2-mdx</t> mouse model. (A) Schematic representation of the in vivo protocol. One month old Dba2/mdx mice were injected with midi-Dys 1, midi-Dys 2, and midi-Dys 3 at a dose of 2.0 × 1013 vg/kg each vector (total dose 4.0 × 1013 vg/kg).
B6 X Dba2 F1 Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dba2/dba+2+mice/pm38810258-23-3-21
Average 90 stars, based on 1 article reviews
b6 x dba2 f1 mice - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Combined therapy: Gene transfer efficiency (A) Schematic representation of the in vivo protocol. Two-month-old D2.Mdx mice were injected or not with two consecutive doses (1 × 10 6 ) of control T cells or of FAP-CAR-T cells, and after 2 weeks of treatment the mice were injected with a single intravenous dose (5 × 10 12 VG/kg) of rAAV9-microdystrophin (μDystrophin or μDys). Tissues were collected 6 weeks after the AAV injection, 4 animals were included per group and statistical analyses used one-way ANOVA tests with p values indicated above the compared conditions. (B) Quantification of VGCN with ddPCR in TA, EDL, and DIA in DBA2-MDX mice. (C) Gene expression analysis of microdystrophin in TA, EDL, and DIA of DBA2-MDX mice. Results are shown as a histogram of relative abundance of gene expression over P0 normalizer gene. (D) Quantification of microdystrophin expression after capillary western blot with DYS-B antibody in TA, EDL, and DIA at 6 weeks post-injection in mice. Values are represented as normalized area under the curve (AUC). (E) Capillary western blot of protein lysates of TA at 6 weeks post-injection in mice. Microdystrophin are visible around 139 kDa. (F) Representative microdystrophin IHF pictures of the TA, EDL, and DIA at 6 weeks post-injection in mice. Images include a scale bar. (G) Quantification of dystrophin positive myofibers in TA, EDL, and DIA at 6 weeks post-injection in D2.mdx mice. The percentage of dystrophin+ fibers is represented of number of dystrophin positive fibers over fibers positive for laminin.

Journal: Molecular Therapy. Methods & Clinical Development

Article Title: FAP-CAR-T cells reduce dystrophic muscle fibrosis, improving adeno-associated virus gene transfer efficacy

doi: 10.1016/j.omtm.2025.101545

Figure Lengend Snippet: Combined therapy: Gene transfer efficiency (A) Schematic representation of the in vivo protocol. Two-month-old D2.Mdx mice were injected or not with two consecutive doses (1 × 10 6 ) of control T cells or of FAP-CAR-T cells, and after 2 weeks of treatment the mice were injected with a single intravenous dose (5 × 10 12 VG/kg) of rAAV9-microdystrophin (μDystrophin or μDys). Tissues were collected 6 weeks after the AAV injection, 4 animals were included per group and statistical analyses used one-way ANOVA tests with p values indicated above the compared conditions. (B) Quantification of VGCN with ddPCR in TA, EDL, and DIA in DBA2-MDX mice. (C) Gene expression analysis of microdystrophin in TA, EDL, and DIA of DBA2-MDX mice. Results are shown as a histogram of relative abundance of gene expression over P0 normalizer gene. (D) Quantification of microdystrophin expression after capillary western blot with DYS-B antibody in TA, EDL, and DIA at 6 weeks post-injection in mice. Values are represented as normalized area under the curve (AUC). (E) Capillary western blot of protein lysates of TA at 6 weeks post-injection in mice. Microdystrophin are visible around 139 kDa. (F) Representative microdystrophin IHF pictures of the TA, EDL, and DIA at 6 weeks post-injection in mice. Images include a scale bar. (G) Quantification of dystrophin positive myofibers in TA, EDL, and DIA at 6 weeks post-injection in D2.mdx mice. The percentage of dystrophin+ fibers is represented of number of dystrophin positive fibers over fibers positive for laminin.

Article Snippet: The DBA2 (B6; 129S4-DBA2tm1Cpr/J, strain no. 000671) (D2) controls mice were purchased directly from Charles River Laboratories) while the DBA2/mdx (D2.B10-Dmdmdx/J, strain no. 013141) (D2.mdx) mice were bred and obtained from the Center d’Exploration et de Recherche Fonctionnelle Expérimentale (CERFE) in Evry, France.

Techniques: In Vivo, Injection, Control, Gene Expression, Expressing, Western Blot

Combined therapy: Histology effects Mice were treated as in A. (A) Representative images with scale bars, of hematoxylin and eosine, Sirius red, alizarine red coloration, and CD11b staining in the TA, EDL, and diaphragm of Dba2-mdx mice 6 weeks post-injection. For Sirius red coloration, red-colored regions are highly fibrotic and contain collagen deposits. For alizarine coloration, brown areas are indicated as a region containing calcium deposits. For CD11b staining, red signals indicate monocytes cells. (B) Quantification of the collagen, calcium deposits area and CD11b cells in the TA of mice. The results are shown as the percentage of fibrotic positive or calcium positive regions over the total area of the muscle cut for colorations. The results for CD11b staining are shown as the percentage of CD11b + cells after nuclei segmentation on R software. Statistical p values are indicated above the compared conditions.

Journal: Molecular Therapy. Methods & Clinical Development

Article Title: FAP-CAR-T cells reduce dystrophic muscle fibrosis, improving adeno-associated virus gene transfer efficacy

doi: 10.1016/j.omtm.2025.101545

Figure Lengend Snippet: Combined therapy: Histology effects Mice were treated as in A. (A) Representative images with scale bars, of hematoxylin and eosine, Sirius red, alizarine red coloration, and CD11b staining in the TA, EDL, and diaphragm of Dba2-mdx mice 6 weeks post-injection. For Sirius red coloration, red-colored regions are highly fibrotic and contain collagen deposits. For alizarine coloration, brown areas are indicated as a region containing calcium deposits. For CD11b staining, red signals indicate monocytes cells. (B) Quantification of the collagen, calcium deposits area and CD11b cells in the TA of mice. The results are shown as the percentage of fibrotic positive or calcium positive regions over the total area of the muscle cut for colorations. The results for CD11b staining are shown as the percentage of CD11b + cells after nuclei segmentation on R software. Statistical p values are indicated above the compared conditions.

Article Snippet: The DBA2 (B6; 129S4-DBA2tm1Cpr/J, strain no. 000671) (D2) controls mice were purchased directly from Charles River Laboratories) while the DBA2/mdx (D2.B10-Dmdmdx/J, strain no. 013141) (D2.mdx) mice were bred and obtained from the Center d’Exploration et de Recherche Fonctionnelle Expérimentale (CERFE) in Evry, France.

Techniques: Staining, Injection, Software

Figure 4. Efficacy of reconstitution of midi-dystrophins in Dba2-mdx mouse model. (A) Schematic representation of the in vivo protocol. One month old Dba2/mdx mice were injected with midi-Dys 1, midi-Dys 2, and midi-Dys 3 at a dose of 2.0 × 1013 vg/kg each vector (total dose 4.0 × 1013 vg/kg).

Journal: International journal of molecular sciences

Article Title: In Silico Structural Prediction for the Generation of Novel Performant Midi-Dystrophins Based on Intein-Mediated Dual AAV Approach.

doi: 10.3390/ijms251910444

Figure Lengend Snippet: Figure 4. Efficacy of reconstitution of midi-dystrophins in Dba2-mdx mouse model. (A) Schematic representation of the in vivo protocol. One month old Dba2/mdx mice were injected with midi-Dys 1, midi-Dys 2, and midi-Dys 3 at a dose of 2.0 × 1013 vg/kg each vector (total dose 4.0 × 1013 vg/kg).

Article Snippet: DBA2 (B6;129S4-DBA2tm1Cpr/J, strain #000671) and DBA2-mdx (D2.B10-Dmdmdx/J) mice were supplied by the Jackson Laboratory.

Techniques: In Vivo, Injection, Plasmid Preparation

Figure 5. Functional and histopathological therapeutic efficacy in Dba2-mdx mice. (A) CPK (creatine phosphokinase) concentration in the sera of Dba2-mdx mice injected with midi-Dys 1-2-3. Results are

Journal: International journal of molecular sciences

Article Title: In Silico Structural Prediction for the Generation of Novel Performant Midi-Dystrophins Based on Intein-Mediated Dual AAV Approach.

doi: 10.3390/ijms251910444

Figure Lengend Snippet: Figure 5. Functional and histopathological therapeutic efficacy in Dba2-mdx mice. (A) CPK (creatine phosphokinase) concentration in the sera of Dba2-mdx mice injected with midi-Dys 1-2-3. Results are

Article Snippet: DBA2 (B6;129S4-DBA2tm1Cpr/J, strain #000671) and DBA2-mdx (D2.B10-Dmdmdx/J) mice were supplied by the Jackson Laboratory.

Techniques: Functional Assay, Drug discovery, Concentration Assay, Injection